Successful Pre- and Post-transplant Administration of Gilteritinib in a Patient with Relapsed and Refractory Acute Myeloid Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Patients with acute myeloid leukemia (AML) harboring FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication mutation are associated with a poor survival outcome, even those receiving allogeneic stem cell transplantation (Allo-SCT). An additional treatment strategy with allo-SCT is therefore r...

Descripción completa

Detalles Bibliográficos
Autores principales: Edahiro, Taro, Ureshino, Hiroshi, Chishaki, Ren, Fujino, Keita, Mino, Tatsuji, Yoshida, Tetsumi, Fukushima, Noriyasu, Ichinohe, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465286/
https://www.ncbi.nlm.nih.gov/pubmed/36450475
http://dx.doi.org/10.2169/internalmedicine.1069-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465286/
https://www.ncbi.nlm.nih.gov/pubmed/36450475
http://dx.doi.org/10.2169/internalmedicine.1069-22

Ejemplares similares